Search
Demystifying International & Interstate Discovery Bill Baton, Vice Chair of the firm's Intellectual Property Practice , will moderate a panel presented by The United States District Court for the District of New Jersey, in conjunction with the Association of the Federal Bar of New Jersey. This...
Obtaining Permanent Residency in the U.S. for H-1B Professionals, Foreign Students and Other Non-immigrant Visa Holders International talent on non-immigrant visas such as H1B, L1A/B and F1 Visa can immediately file for Adjustment of Status along with their Application for EB-5 Visa. Rohit Kapuria...
RIA: EB-5 Industry Experts Help You Prepare for New Changes, co-hosted by JTC Americas and Saul Ewing LLP.
RIA: EB-5 Industry Experts Help You Prepare for New Changes, co-hosted by JTC Americas and Saul Ewing LLP.
RIA: EB-5 Industry Experts Help You Prepare for New Changes, co-hosted by JTC Americas and Saul Ewing LLP.
RIA: EB-5 Industry Experts Help You Prepare for New Changes, co-hosted by JTC Americas and Saul Ewing LLP.
RIA: EB-5 Industry Experts Help You Prepare for New Changes, co-hosted by JTC Americas and Saul Ewing LLP.
RIA: EB-5 Industry Experts Help You Prepare for New Changes, co-hosted by JTC Americas and Saul Ewing LLP.
RIA: EB-5 Industry Experts Help You Prepare for New Changes, co-hosted by JTC Americas and Saul Ewing LLP.
Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...
Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...